|
Portage Biotech Inc (PRTG) |
|
Portage Biotech Inc
PRTG's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Portage Biotech Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -0.28 %
Portage Biotech Inc net loss increased from $-19 millions, to $-75 millions in IV. Quarter 2024,
• More on PRTG's Growth
|
|
Portage Biotech Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.03 in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.
• More on PRTG's Valuation
|
|
|
|
|
Portage Biotech Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.03 in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.
Portage Biotech Inc Price to Book Ratio is at 0.1 lower than Industry Avg. of 85.07. and higher than S&P 500 Avg. of 0
• More on PRTG's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com